On the public citation graph
Role of Magnetic Resonance Imaging in Thyroid-Associated Ophthalmopathy: Its Predictive Value for Therapeutic Outcome of Immunosuppressive Therapy
0 signed · 128 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/bf00154461openalex-snapshot
Correlation between NMR scans of extraocular muscles and clinical symptoms in Graves' ophthalmopathy
inferredcites →https://doi.org/10.1016/0002-9343(77)90325-4openalex-snapshot
Hypothyroid Graves' disease
inferredcites →https://doi.org/10.1016/0014-5793(88)80402-2openalex-snapshot
Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid‐associated ophthalmopathy
inferredcites →https://doi.org/10.1016/0167-5699(91)90079-9openalex-snapshot
Thyroid-associated ophthalmopathy ? a model for the association of organ-specific autoimmune disorders
inferredcites →https://doi.org/10.1016/s0161-6420(81)34993-8openalex-snapshot
Correlation of CT Scanning and Pathologic Features of Ophthalmic Graves' Disease
inferredcites →https://doi.org/10.1056/nejm197406272902602openalex-snapshot
Ultrasonographic Evidence of a Consistent Orbital Involvement in Graves's Disease
inferredcites →https://doi.org/10.1056/nejm198911163212001openalex-snapshot
Use of Corticosteroids to Prevent Progression of Graves' Ophthalmopathy after Radioiodine Therapy for Hyperthyroidism
inferredcites →https://doi.org/10.1056/nejm198911163212002openalex-snapshot
Prednisone and Cyclosporine in the Treatment of Severe Graves' Ophthalmopathy
inferredcites →https://doi.org/10.1111/j.1365-2265.1979.tb03036.xopenalex-snapshot
THYROID BINDING ANTIBODIES AND OTHER IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WITH GRAVES’OPHTHALMOPATHY: EFFECT OF TREATMENT WITH CYCLOPHOSPHAMIDE
inferredcites →https://doi.org/10.1136/bmj.2.6191.667-copenalex-snapshot
Exophthalmos and pretibial myxoedema not responding to plasmapheresis.
inferredcites →https://doi.org/10.1136/bmj.288.6425.1183openalex-snapshot
A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
inferredcites →https://doi.org/10.1136/bmj.297.6663.1574openalex-snapshot
Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.
inferredcites →https://doi.org/10.1136/bmj.298.6676.830openalex-snapshot
Methylprednisolone and Graves' ophthalmopathy.
inferredcites →https://doi.org/10.1148/radiology.179.1.2006276openalex-snapshot
Graves ophthalmopathy: role of MR imaging in radiation therapy.
inferredcites →https://doi.org/10.1210/jcem-37-2-276openalex-snapshot
Supervoltage Orbital Radiotherapy for Graves' Ophthalmopathy1
inferredcites →https://doi.org/10.1210/jcem-44-1-203openalex-snapshot
Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association
inferredcites →https://doi.org/10.1210/jcem-67-3-565openalex-snapshot
A Thyroid Cytotoxic Antibody That Cross-reacts With an Eye Muscle Cell Surface Antigen May Be the Cause of Thyroid-Associated Ophthalmopathy*
inferredcites →https://doi.org/10.1210/jcem-69-3-622openalex-snapshot
Presence of Antibodies in the Sera of Patients with Graves' Disease Recognizing a 23 Kilodalton Fibroblast Protein*
inferredcites →https://doi.org/10.1210/jcem-72-6-1375openalex-snapshot
Cloning and Sequencing of a Novel 64-kDa Autoantigen Recognized by Patients with Autoimmune Thyroid Disease*
inferredcites →https://doi.org/10.1530/acta.0.1150030openalex-snapshot
A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells
inferredcites →https://doi.org/10.1530/acta.0.1160513openalex-snapshot
Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy
inferredcites →https://doi.org/10.3109/08916939009002979openalex-snapshot
Significance of Cytotoxic Eye Muscle Antibodies in Patients with Thyroid-Associated Ophthalmopathy
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4760256openalex-extracted
Rdinet: A Dynamic Mapping Model for Multimodal Feature Fusion for Treatment Response Prediction In Thyroid Eye Disease
inferred← citeshttps://doi.org/10.1001/jamaoto.2014.3659openalex-snapshot
Proptosis Reduction by Clinical vs Radiological Modalities and Medial vs Inferomedial Approaches
inferred← citeshttps://doi.org/10.1002/jcu.20154openalex-snapshot
Graves' Ophthalmopathy: Comparison of the Doppler sonography parameters with the clinical activity score
inferred← citeshttps://doi.org/10.1002/jmri.29114openalex-snapshot
Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices
inferred← citeshttps://doi.org/10.1007/978-1-4615-1447-3_11openalex-snapshot
Assessment of Disease Activity
inferred← citeshttps://doi.org/10.1007/978-1-4615-1447-3_4openalex-snapshot
Role of Cytokines in the Pathogenesis of Graves’ Ophthalmopathy
inferred← citeshttps://doi.org/10.1007/978-1-4615-1447-3_9openalex-snapshot
Imaging in Graves’ Ophthalmopathy
inferred← citeshttps://doi.org/10.1007/978-1-4615-4647-4_3openalex-snapshot
Assessment of disease severity
inferred← citeshttps://doi.org/10.1007/978-1-4615-4647-4_4openalex-snapshot
Assessment of disease activity of Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1007/978-981-32-9220-8_3openalex-snapshot
Orbital Imaging for Orbital Decompression
inferred← citeshttps://doi.org/10.1007/bf02988642openalex-snapshot
The role of Tc-99m polyclonal human immunoglobulin G scintigraphy in Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1007/bf03344124openalex-snapshot
Slow-release lanreotide in Graves’ ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial
inferred← citeshttps://doi.org/10.1007/bf03345274openalex-snapshot
Recent developments in Graves’ ophthalmopathy imaging
inferred← citeshttps://doi.org/10.1007/pl00022537openalex-snapshot
Wertigkeit der neuroradiologischen Bildgebung bei der endokrinen Orbitopathie
inferred← citeshttps://doi.org/10.1007/s002590050419openalex-snapshot
Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.1007/s002590050519openalex-snapshot
Graves' ophthalmopathy: diagnosis and management
inferred← citeshttps://doi.org/10.1007/s00521-023-08727-2openalex-snapshot
A novel encoder–decoder wavelet model for multifocal region segmentation of TAO facial images
inferred← citeshttps://doi.org/10.1007/s10384-014-0365-xopenalex-snapshot
Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.1007/s10384-026-01372-xopenalex-snapshot
Reduction in extraocular muscle and orbital fat volumes after teprotumumab treatment in Japanese patients with thyroid eye disease: an exploratory magnetic resonance imaging analysis from the OPTIC-J trial
inferred← citeshttps://doi.org/10.1007/s12020-020-02367-5openalex-snapshot
Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues
inferred← citeshttps://doi.org/10.1007/s12020-025-04364-yopenalex-snapshot
Orbital MRI and clinical activity score for predicting steroid treatment response in moderate-to-severe Graves’ orbitopathy
inferred← citeshttps://doi.org/10.1016/b978-0-323-18907-1.00083-4openalex-snapshot
Graves’ Ophthalmopathy
inferred← citeshttps://doi.org/10.1016/b978-1-4160-0016-7.50232-0openalex-snapshot
Pathophysiology of Graves' Orbitopathy
inferred← citeshttps://doi.org/10.1016/b978-1-4160-2311-1.00018-4openalex-snapshot
Orbital disease in neuro-ophthalmology
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5583-9.00081-2openalex-snapshot
Graves’ Ophthalmopathy
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1151-6.00012-4openalex-snapshot
Selected References
inferred← citeshttps://doi.org/10.1016/j.beem.2011.11.009openalex-snapshot
Neuroimaging of Graves’ orbitopathy
inferred← citeshttps://doi.org/10.1016/j.crad.2022.08.124openalex-snapshot
MRI in the assessment of thyroid-associated orbitopathy activity
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.07.007openalex-snapshot
Thyroid-Stimulating Antibody/Thyroid-Stimulating Hormone Receptor Antibody Ratio as a Sensitive Screening Test for Active Graves’ Orbitopathy
inferred← citeshttps://doi.org/10.1016/j.jaapos.2018.06.002openalex-snapshot
Management of graves myopathy
inferred← citeshttps://doi.org/10.1016/j.jfma.2018.06.009openalex-snapshot
The impact of orbital bony or fat decompression on the outcome of strabismus surgery in patients with Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1016/j.jfo.2013.07.004openalex-snapshot
Prise en charge diagnostique et thérapeutique d’une orbitopathie dysthyroïdienne : une affection multidisciplinaire
inferred← citeshttps://doi.org/10.1016/j.oftal.2011.06.010openalex-snapshot
Evaluación de la órbita mediante secuencias short-tau inversion-recovery (STIR) en resonancia nuclear magnética en la orbitopatía de Graves
inferred← citeshttps://doi.org/10.1016/j.oftale.2011.06.004openalex-snapshot
Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves’ orbitopathy
inferred← citeshttps://doi.org/10.1016/j.sjopt.2012.07.006openalex-snapshot
Update on advanced imaging options for thyroid-associated orbitopathy
inferred← citeshttps://doi.org/10.1038/s41598-017-17257-6openalex-snapshot
Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity
inferred← citeshttps://doi.org/10.1038/s41598-019-38640-5openalex-snapshot
Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease
inferred← citeshttps://doi.org/10.1038/s41598-020-76341-6openalex-snapshot
Histogram analysis of T2 mapping for detecting early involvement of extraocular muscles in patients with thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.1038/srep16672openalex-snapshot
Genetic Associations of Interleukin-related Genes with Graves’ Ophthalmopathy: a Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1046/j.1365-2265.1999.00681.xopenalex-snapshot
Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy
inferred← citeshttps://doi.org/10.1046/j.1365-2265.2000.00973.xopenalex-snapshot
Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters
inferred← citeshttps://doi.org/10.1046/j.1365-2265.2001.01220.xopenalex-snapshot
The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy
inferred← citeshttps://doi.org/10.1089/105072502753600160openalex-snapshot
Role of Cytokines in the Pathogenesis of Thyroid-Associated Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/105072502753600179openalex-snapshot
Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/thy.1995.5.107openalex-snapshot
Role of Octreoscan and Correlation with MR Imaging in Graves' Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/thy.1995.5.185openalex-snapshot
MR T2 Relaxation Time for the Assessment of Retrobulbar Inflammation in Graves' Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/thy.1996.6.381openalex-snapshot
The Effect of Somatostatin versus Corticosteroid in the Treatment of Graves' Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/thy.1996.6.553openalex-snapshot
Localization and Clinical Significance of Thyrotropin Receptor mRNA Expression in Orbital Fat and Eye Muscle Tissues from Patients with Thyroid-Associated Ophthalmopathy
inferred← citeshttps://doi.org/10.1089/thy.1999.9.341openalex-snapshot
Increased Serum Soluble Fas in Patients with Graves' Disease
inferred← citeshttps://doi.org/10.1089/thy.2005.15.358openalex-snapshot
Orbital Gallium-67 Scintigraphy in Graves' Ophthalmopathy: A Disease Activity Parameter that Predicts the Therapeutic Response to Immunosuppressive Treatment
inferred← citeshttps://doi.org/10.1093/med/9780199235292.003.3205openalex-snapshot
Graves’ ophthalmopathy and dermopathy
inferred← citeshttps://doi.org/10.1097/00004728-200005000-00025openalex-snapshot
Normative Measurements of Orbital Structures Using MRI
inferred← citeshttps://doi.org/10.1097/00006231-200111000-00001openalex-snapshot
Radioiodine and Gravesʼ ophthalmopathy reconsidered
inferred← citeshttps://doi.org/10.1097/01.rct.0000146112.56194.24openalex-snapshot
Evaluation of Extraocular Muscles Using Dynamic Contrast Enhanced MRI in Patients With Chronic Thyroid Orbitopathy
inferred← citeshttps://doi.org/10.1097/iop.0000000000002511openalex-snapshot
Magnetic Resonance Imaging in the Management of Thyroid Eye Disease: A Systematic Review
inferred← citeshttps://doi.org/10.1097/wno.0b013e31814a5ef8openalex-snapshot
Efficacy of Corticosteroids and External Beam Radiation in the Management of Moderate to Severe Thyroid Eye Disease
inferred← citeshttps://doi.org/10.1111/cen.14178openalex-snapshot
Low signal intensities of MRI T1 mapping predict refractory diplopia in Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1111/j.1365-2265.2004.02044.xopenalex-snapshot
Comparison of practical methods for urinary glycosaminoglycans and serum hyaluronan with clinical activity scores in patients with Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1111/j.1365-2265.2005.02186.xopenalex-snapshot
Measuring disease activity to predict therapeutic outcome in Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1111/j.1600-0420.2005.00617.xopenalex-snapshot
Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid‐associated ophthalmopathy and proptosis
inferred← citeshttps://doi.org/10.1155/2015/835979openalex-snapshot
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
inferred← citeshttps://doi.org/10.1159/000320434openalex-snapshot
Management of Mild Graves’ Orbitopathy
inferred← citeshttps://doi.org/10.1159/000475955openalex-snapshot
Management of Mild Graves' Orbitopathy
inferred← citeshttps://doi.org/10.1177/20552076261443669openalex-snapshot
RDINet: A novel dynamic mapping model integrating radiomics and deep learning for predicting treatment response in thyroid eye disease
inferred← citeshttps://doi.org/10.1186/s13044-026-00293-8openalex-snapshot
A preliminary study developing a scoring model incorporating fibrinogen-like protein 2 for predicting glucocorticoid resistance in thyroid eye disease
inferred← citeshttps://doi.org/10.1210/clinem/dgag348openalex-snapshot
Teprotumumab effects on thyroid eye disease in a Japanese MRI study: comparison with intravenous glucocorticoid therapy
inferred← citeshttps://doi.org/10.1210/jc.2004-1334openalex-snapshot
Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study
inferred← citeshttps://doi.org/10.1210/jc.2014-4542openalex-snapshot
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study
inferred← citeshttps://doi.org/10.1258/ar.2011.110431openalex-snapshot
Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity
inferred← citeshttps://doi.org/10.1259/bjr.75.894.750514openalex-snapshot
Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
inferred← citeshttps://doi.org/10.14341/ket20106316-23openalex-snapshot
Treatment of Graves' ophthalmopathy
inferred← citeshttps://doi.org/10.14341/probl20135953-8openalex-snapshot
The potential of magnetic resonance visualization of the orbits for diagnostics of endocrine ophthalmopathy
inferred← citeshttps://doi.org/10.1507/endocrj.42.441openalex-snapshot
Thyroid Stimulating Antibody in Sera of Graves' Ophthalmopathy Patients as a Possible Marker for Predicting the Efficacy of Methylprednisolone Pulse Therapy.
inferred← citeshttps://doi.org/10.1507/endocrj.51.399openalex-snapshot
Immunohistochemical Analysis of Bcl-2, Bax and Bak Expression in Thyroid Glands from Patients with Graves' Disease
inferred← citeshttps://doi.org/10.1507/endocrj.ej15-0137openalex-snapshot
TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves’ ophthalmopathy in untreated Japanese Graves’ disease patients
inferred← citeshttps://doi.org/10.1507/endocrj.ej16-0083openalex-snapshot
Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves’ ophthalmopathy: a prospective, randomized controlled trial
inferred← citeshttps://doi.org/10.1507/endocrj.ej19-0398openalex-snapshot
Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.1507/endocrj.ej24-0347openalex-snapshot
Transition from hypothyroidism to Graves’ disease, development of thyroid eye disease, progression to optic neuropathy after inpatient pulse therapy, and long-term administration of outpatient pulse therapy: a case report with review of literature
inferred← citeshttps://doi.org/10.1507/endocrj.k10e-156openalex-snapshot
Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy
inferred← citeshttps://doi.org/10.1530/eje.0.1450107openalex-snapshot
Imaging in thyroid-associated orbitopathy
inferred← citeshttps://doi.org/10.1530/etj-24-0122openalex-snapshot
Prediction models of intravenous glucocorticoids therapy response in thyroid eye disease
inferred← citeshttps://doi.org/10.1590/s0004-27492006000600006openalex-snapshot
Colchicine in the treatment of the inflammatory phase of Graves' ophthalmopathy: a prospective and randomized trial with prednisone
inferred← citeshttps://doi.org/10.2147/imcrj.s177671openalex-snapshot
Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease
inferred← citeshttps://doi.org/10.2147/opth.s105096openalex-snapshot
Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy
inferred← citeshttps://doi.org/10.2147/opth.s118555openalex-snapshot
Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
inferred← citeshttps://doi.org/10.2147/opth.s476562openalex-snapshot
Efficacy and Systemic Effects of a Single Deep Orbital Triamcinolone Injection for Thyroid Eye Disease
inferred← citeshttps://doi.org/10.2169/internalmedicine.53.1518openalex-snapshot
Graves' Ophthalmopathy: Epidemiology and Natural History
inferred← citeshttps://doi.org/10.2169/naika.99.755openalex-snapshot
1. Advances in the Pathogenesis and Management of Graves' Ophthalmopathy.
inferred← citeshttps://doi.org/10.3109/01676839609150232openalex-snapshot
In situ studies of orbital tissue from patients with thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.3109/01676839609150234openalex-snapshot
New imaging procedures in thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.3109/01676839609150235openalex-snapshot
Advances in medical therapy of thyroid-associated ophthalmopathy
inferred← citeshttps://doi.org/10.3174/ajnr.a4859openalex-snapshot
Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy
inferred← citeshttps://doi.org/10.3389/fendo.2022.991588openalex-snapshot
Current insights of applying MRI in Graves’ ophthalmopathy
inferred← citeshttps://doi.org/10.3389/fendo.2023.1292519openalex-snapshot
Predictive markers for anti-inflammatory treatment response in thyroid eye disease
inferred← citeshttps://doi.org/10.3389/fendo.2025.1537957openalex-snapshot
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy
inferred← citeshttps://doi.org/10.4158/ep-2019-0133openalex-snapshot
Role of Magnetic Resonance Imaging in the Assessment of Active Thyroid-Associated Ophthalmopathy Patients with Long Disease Duration
inferred← citeshttps://doi.org/10.5772/53441openalex-snapshot
Genetic Susceptibility to Graves’ Ophthalmopathy
inferred← citeshttps://doi.org/10.5772/58555openalex-snapshot
Graves’ Ophthalmopathy Imaging Evaluation
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.